EP3022189 - Bibliographic data
MODULATEURS 4-(3-CYANOPHÉNYL)-6-PYRIDINYLPYRIMIDINE DE MGLU5
| Last update | 16/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
HEPTARES THERAPEUTICS LIMITED BioPark
Broadwater Road
Welwyn Garden City, Hertfordshire AL7 3AX
Royaume-Uni
|
|---|---|
| (72) Inventors |
John CHRISTOPHER c/o Heptares Therapeutics Limited
BioPark
Broadwater Road
Welwyn Garden City
Hertfordshire AL7 3AX
Royaume-Uni
Miles CONGREVE c/o Heptares Therapeutics Limited
BioPark
Broadwater Road
Welwyn Garden City
Hertfordshire AL7 3AX
Royaume-Uni
Sarah AVES c/o Heptares Therapeutics Limited
BioPark
Broadwater Road
Welwyn Garden City
Hertfordshire AL7 3AX
Royaume-Uni
Benjamin TEHAN c/o Heptares Therapeutics Limited
BioPark
Broadwater Road
Welwyn Garden City
Hertfordshire AL7 3AX
Royaume-Uni
|
| (74) Agent |
Mail recipient Stratagem IPM Limited Meridian Court
Comberton Road
Toft, Cambridge CB23 2RY
Royaume-Uni
|
| (21) Request number | EP14742326.3 |
|---|---|
| (22) Request date | 17/07/2014 |
| (11) Publication number | EP3022189 |
|---|---|
| Publication date | 26/09/2018 |
| (54) Title of the invention | MODULATEURS 4-(3-CYANOPHÉNYL)-6-PYRIDINYLPYRIMIDINE DE MGLU5 |
|---|---|
| (51) International classification | C07D 401/04, A61K 31/506, C07D 403/04, C07D 239/26, A61P 25/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201312800 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 6 -
Amount: 115 € -
Due date 31/07/2019
Surtax: 6 - Amount: 23 € - Due date 03/02/2020 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 26/09/2018 Entrée en période de grâce du brevet d'invention - Legal date 01/08/2019 Déchéance du brevet d'invention après période de grâce - Legal date 31/07/2019 |